Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency
about
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirusBiphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoHuman cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition.Systemic hematogenous maintenance of memory inflation by MCMV infection.Human Cytomegalovirus Latency: Approaching the Gordian Knot.Allogeneic stimulation causes transcriptional reactivation of latent murine cytomegalovirus.Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunityReactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures.Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue.Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent miceTRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivationReversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway.The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.Inhibition of IL-1beta transcription by peptides derived from the hCMV IE2 transactivator.Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.Establishment of murine cytomegalovirus latency in vivo is associated with changes in histone modifications and recruitment of transcriptional repressors to the major immediate-early promoter.Epigenetic control of cytomegalovirus latency and reactivation.Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.Roles of neural stem progenitor cells in cytomegalovirus infection of the brain in mouse models.The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency.Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.Epigenetic regulation of human cytomegalovirus latency: an update.Tissue-specific control of latent CMV reactivation by regulatory T cells.Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions.A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionHuman cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor.Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6A mouse model of interstitial pneumonitis induced by murine cytomegalovirus infection after allogeneic skin transplantationMurine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus.
P2860
Q31050845-F4C5179B-663B-4DEB-B922-C7B362A3A2D5Q33725662-E3FBA8ED-724A-47E4-AEF4-E92C89E8C4E3Q33747809-65085B9F-187F-45C4-967B-F034E3A736E4Q33845720-41E1CC7A-69EA-44F4-A32E-DDC594FC7B0CQ33912815-332CE043-301E-4188-A7CD-435CCF2BC7B8Q34048734-6A980A0D-E0F3-47FC-9855-488C63A77A40Q34227634-47B0A209-A2DA-4950-82AF-1C697F078706Q34342396-40B97747-8765-45B3-A5B4-BC5BC9221EC5Q34346013-045207CE-42B2-45AB-931D-D197A422BA76Q34415946-EA918C5A-E78A-45E7-82FE-1C4B9763D55EQ34676355-9E31DBDC-F780-4BDA-B74F-50E24094F757Q35024244-2D7A8860-B8DC-48B9-B740-ECA2961B35F7Q35076765-E767ED4F-2036-4FB9-B768-B10AA103EE1AQ35139332-03EF57F7-CBB3-4ADC-A314-4787218D2D19Q35382729-F2C28114-3550-4EC2-B938-4348862D8F91Q35857316-5C4EF9A8-BC17-4328-AF35-9339F759D19FQ35857513-EA0EF5BC-B888-4A2B-A8ED-5342A01C6E33Q36620691-86917B8C-6978-47CE-9167-E52D193FF789Q36862292-DA0FD6A4-4D98-476B-BA02-6E426CFB4FB7Q36949670-743788C7-B5C0-4359-9E50-F669EA15F33CQ37015743-1629A322-A0EC-4629-A806-976CEC4910D8Q37060516-289C5898-59D0-4688-8BC3-3DDA6AA3D61FQ37145096-76848678-BE63-4252-ABA1-2877AEB27A7EQ37157169-2620145F-3771-42C0-B8BC-99BAAB220113Q37256740-FC8103B1-1CAB-4B28-8314-DCBF11AE031DQ37611802-19DE7417-15EE-4D05-894F-BE7B8BC62531Q37747368-06087D46-1F03-4728-860D-F5ADD5A01303Q38044678-DBDA8F69-DC09-434A-9695-B83FA66513D0Q38272313-F719ADF5-795F-41BB-93F8-860E99B47141Q38630384-66AF7639-ABBD-40EF-BE4A-EC1FEF89ACD4Q38703382-0CFBB87E-F473-40BB-BDD2-B859803711E3Q39105335-801D387E-9ED6-477D-8E15-54A339BA73A3Q39320231-BAB60358-CEA9-4E5B-8ADC-147C805D9839Q39462585-6D96E7AC-E4A8-4FC2-8E75-9B2EECEC77CEQ39627859-78D13F50-B641-4A44-8C1C-234FF0DD9A52Q39652186-76777107-0D4A-4D68-8A78-8F46666C9995Q39699587-DFAFE67A-D7E5-4D4F-81A1-7DE6C07ADE22Q41783854-C8FF5DB5-BAAF-4B16-B568-E2AC1A13C019Q41987319-FA17179C-7BA5-4488-93EA-FF32A54FD78FQ42090485-02921F5D-9E08-4B54-9897-A7E546F1A6EF
P2860
Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Allogeneic transplantation ind ...... for reactivation from latency
@ast
Allogeneic transplantation ind ...... for reactivation from latency
@en
type
label
Allogeneic transplantation ind ...... for reactivation from latency
@ast
Allogeneic transplantation ind ...... for reactivation from latency
@en
prefLabel
Allogeneic transplantation ind ...... for reactivation from latency
@ast
Allogeneic transplantation ind ...... for reactivation from latency
@en
P2093
P2860
P1433
P1476
Allogeneic transplantation ind ...... for reactivation from latency
@en
P2093
M I Abecassis
T Varghese
P2860
P304
P356
10.1128/JVI.75.10.4814-4822.2001
P577
2001-05-01T00:00:00Z